diabetes (425 million), and it is estimated that the numbers will increase up to 642 million by 2040 (https://www.cdc.gov/cancer/colorectal/statistics/index.htm,2018;http://www.diabetesatlas.org/.,2018). T2DM is associated with the three cancers that arepancreatic cancer, breast cancer ...
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA: A Cancer Journal for Clinicians.2024;74(3):229-263. doi:10.3322/caac.21834 ...
Apoptosis evasion via long non-coding RNAs in colorectal cancer Muhammad Irfan Zeeshan Javed William C. Cho Cancer Cell International (2022) Emerging roles for lncRNA-NEAT1 in colorectal cancer Shirin Azizidoost Farhoodeh Ghaedrahmati Maryam Farzaneh Cancer Cell International (2022)Download...
SATURDAY, Feb. 24, 2024 (HeathDay News)—Colon cancer rates are on the rise among young Americans and Americans of color, so much so that the disease is now the leading cause of cancer death for men under 50 and the second most deadly cancer for women un
Worldwide, CRC is the third most common cancer. These numbers make clear that CRC affects both men and women, in contrast to a myth that CRC is primarily a man’s cancer. The good news is that most colon cancers are preventable! YES! Yet, why are the statistics so large? Here are ...
Colorectal cancer statistics, 2023. Cancer J Clin. 2023;73(3):233–54. Article Google Scholar Morgan E et al. Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut 72.2 (2023): 338–344. Nadeem M, Shahid et al. Risk of colorectal ...
Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells Article Open access 29 July 2024 Characteristics of circulating adaptive immune cells in patients with colorectal cancer Article Open access 28 October 2022 Introd...
2022, Pathology Research and Practice Citation Excerpt : This may be because of its ability to promote cancer cell motility, invasiveness, and metastatic potential. Recently, TB has been shown to be a poor prognostic factor in colorectal cancer [3,38]. The association between OPN and TB shown...
Colon cancer is a prevalent malignancy, while recent studies revealed the dys-regulation of Hippo signaling as the important driver for colon cancer progression. Several studies have indicated that post-translational modifications on YAP play crucial rol
The Colorectal Cancer Subtyping Consortium established four Consensus Molecular Subtypes (CMS) in colorectal cancer: CMS1 (microsatellite-instability [MSI], Immune), CMS2 (Canonical, epithelial), CMS3 (Metabolic), and CMS4 (Mesenchymal). However, only MSI tumour patients have seen a change in the...